Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine (Seroquel) 400 mg vs 800 mg vs placebo in adolescents with schizophrenia
2004-000750-22Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of quetiapine in schizophrenia (3 arms), sponsored by AstraZeneca. Primary endpoint: Change from baseline to Day 42 in PANSS total score. Started Feb 2006; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2004-000750-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000750-22.